These emerging treatments , including Rybelsus, belong to a class of drugs called GLP-1 agents. Originally intended for treating type 2 diabetes , they operate by assisting the body to release more insulin production and curbing high glucose levels. Beyond diabetes, their potential to support weight management has contributed to increased intere… Read More